pulver til injektionsvæske

DRUG5 trials

Sponsors

Rigshospitalet, Rigshospitalet, Rigshospitalet, Aarhus Universitetshospital, Region Hovedstaden, Gentofte Hospital, Frederiksberg Hospital

Conditions

Diabetic neuropathic painGram-negative BacteremiaHidradenitis SuppurativaNeuropathyTrigeminal neuralgia

Phase 2

Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: A double-blind, randomized, placebo-controlled study (PINBOT)

RecruitingCTIS2022-500727-68-01

RigshospitaletDiabetic neuropathic pain

Start: 2023-08-07Target: 80Updated: 2024-04-22

Phase 3

Safety and efficacy of botulinum toxin A in patients with trigeminal neuralgia: a double-blind, randomized, placebo-controlled, parallel-group trial and investigation of neuro-inflammatory biomarkers as predictors of efficacy

RecruitingCTIS2023-504567-17-00

Rigshospitalet, RigshospitaletTrigeminal neuralgia

Start: 2023-11-15Target: 80Updated: 2025-08-14

Phase 4

The effect of perineural botox on chronic cutaneous neuropathic pain

CompletedCTIS2023-507259-31-00

Aarhus UniversitetshospitalNeuropathy

End: 2024-11-18Target: 50Updated: 2023-10-16

Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study

RecruitingCTIS2024-514900-16-00

Region HovedstadenGram-negative Bacteremia

Start: 2024-07-25Target: 380Updated: 2025-09-12

Botox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study

RecruitingCTIS2024-519946-54-00

Gentofte Hospital, Frederiksberg HospitalHidradenitis Suppurativa

Start: 2025-04-01Target: 20Updated: 2025-04-10

Related Papers

Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: protocol for a phase II, single-centre, double-blind, randomised, placebo-controlled trial (the PINBOT study)

BMJ Open2024-01-012 citations